Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000142

EVP, Chf GL Pdt Str Ofcr sold 37,277 shares at an average $75.85 ($2,827,325)

  • EVP, Chf GL Pdt Str Ofcr acquired 37,277 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jenne Kyle · EVP, Chf GL Pdt Str Ofcr

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-10 Exercise or conversion : show line 1 in the form 10b5-1 +32,602 $46.10 $1,502,952 48,991 D
2026-03-10 Sale : show line 2 in the form 10b5-1 −21,191 $75.50 $1,599,963 27,800 D
2026-03-10 Sale : show line 3 in the form 10b5-1 −16,086 $76.30 $1,227,362 11,714 D
2026-03-10 Exercise or conversion : show line 4 in the form 10b5-1 +4,675 $34.69 $162,176 16,389 D
Open-market sales · 37,277 sh · avg $75.85 · $2,827,325

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-10 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −4,675 14,025 D
2026-03-10 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −32,602 32,601 D
Loading xslF345X05/edgardoc.xml…